다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Process biochemistry, v.50 no.12, 2015년, pp.2242 - 2250
Yuan, T. , He, L. , Yang, J. , Zhang, L. , Xiao, Y. , Fan, Y. , Zhang, X.
AI-Helper
Bioactive factors were added into hydrogel scaffolds to overcome the shortcomings of their low cell affinity and poor bioactivity, as well as limited cell spreading ability for anchorage-dependent cells such as chondrocytes, MSCs, etc. But the direct addition of these bioactive factors may lead to h...
Histol. Histopathol. Gardner 28 23 2014 Chondrogenesis of mesenchymal stem cells for cartilage tissue engineering
Nat. Rev. Rheumatol. Makris 11 21 2014 10.1038/nrrheum.2014.157 Repair and tissue engineering techniques for articular cartilage
Orthopedics Liu 36 868 2013 10.3928/01477447-20131021-10 Tissue engineering stratified scaffolds for articular cartilage and subchondral bone defects repair
Tissue Eng. Part B Rev. Madry 20 106 2014 10.1089/ten.teb.2013.0271 Transforming growth factor Beta-releasing scaffolds for cartilage tissue engineering
Biomaterials Kim 32 8771 2011 10.1016/j.biomaterials.2011.08.073 Hydrogel design for cartilage tissue engineering: a case study with hyaluronic acid
J. Biomed. Mater. Res. A Kopesky 102 1275 2014 10.1002/jbm.a.34789 Sustained delivery of bioactive TGF-beta1 from self-assembling peptide hydrogels induces chondrogenesis of encapsulated bone marrow stromal cells
J. Biomed. Mater. Res. A Reyes 102 1110 2014 10.1002/jbm.a.34769 Cartilage repair by local delivery of transforming growth factor-beta1 or bone morphogenetic protein-2 from a novel, segmented polyurethane/polylactic-co-glycolic bilayered scaffold
Biotechnol. Prog. Yuan 26 1749 2010 10.1002/btpr.484 Chondrogenic differentiation and immunological properties of mesenchymal stem cells in collagen type I hydrogel
J. Biomed. Mater. Res. B Appl. Biomater. Yuan 102 337 2014 10.1002/jbm.b.33011 Collagen hydrogel as an immunomodulatory scaffold in cartilage tissue engineering
J. Mater. Sci. Mater. Med. Guo 23 2267 2012 10.1007/s10856-012-4684-5 Hydrogels of collagen/chondroitin sulfate/hyaluronan interpenetrating polymer network for cartilage tissue engineering
Expert Opin. Drug Deliv. Sohier 5 543 2008 10.1517/17425247.5.5.543 Critical factors in the design of growth factor releasing scaffolds for cartilage tissue engineering
Nutr. Res. Liu 30 57 2010 10.1016/j.nutres.2009.10.020 Icariin protects murine chondrocytes from lipopolysaccharide-induced inflammatory responses and extraular matrix degradation
Eur. J. Pharmacol. Xu 642 146 2010 10.1016/j.ejphar.2010.05.012 Icariin attenuates LPS-induced acute inflammatory responses: involvement of PI3K/Akt and NF-kappaB signaling pathway
Osteoarthritis Cartilage Li 20 1647 2012 10.1016/j.joca.2012.08.009 A potential promoting compound for cartilage tissue engineering
Phytother. Res. Zhang 26 1385 2012 10.1002/ptr.3733 Icariin promotes extracellular matrix synthesis and gene expression of chondrocytes in vitro
Biomacromolecules Tran 12 2872 2011 10.1021/bm200326g In situ forming and rutin-releasing chitosan hydrogels as injectable dressings for dermal wound healing
J. Control Release Yamaguchi 81 235 2002 10.1016/S0168-3659(02)00060-3 Insulin-loaded biodegradable PLGA microcapsules: initial burst release controlled by hydrophilic additives
J. Control Release Yang 205 206 2015 10.1016/j.jconrel.2015.02.008 Hyaluronic acid nanogels with enzyme-sensitive cross-linking group for drug delivery
J. Control Release Zhao 141 30 2010 10.1016/j.jconrel.2009.06.032 The osteogenic effect of bone morphogenetic protein-2 on the collagen scaffold conjugated with antibodies
Mater. Lett. He 136 41 2014 10.1016/j.matlet.2014.08.006 Preparation and characterization of a novel hyaluronic acid-icariin conjugate hydrogel
Biotechnol. Bioeng. Chen 101 821 2008 10.1002/bit.21953 Co-conjugating chondroitin-6-sulfate/dermatan sulfate to chitosan scaffold alters chondrocyte gene expression and signaling profiles
Biomaterials Wang 35 2207 2014 10.1016/j.biomaterials.2013.11.070 Modulation of chondrocyte functions and stiffness-dependent cartilage repair using an injectable enzymatically crosslinked hydrogel with tunable mechanical properties
Macromol. Res. Ahn 22 1024 2014 10.1007/s13233-014-2155-1 Core-shell type complex gelatin scaffold systems for controlled drug release
Mater. Chem. Phys. Meng 125 606 2011 10.1016/j.matchemphys.2010.10.010 Fabrication, characterization and in vitro drug release behavior of electrospun PLGA/chitosan nanofibrous scaffold
J. Mater. Sci. Mater. Med. Fan 23 399 2012 10.1007/s10856-011-4491-4 A combined chitosan/nano-size hydroxyapatite system for the controlled release of icariin
Mol. Med. Rep. Huang 8 1221 2013 10.3892/mmr.2013.1624 Dual-delivery of vancomycin and icariin from an injectable calcium phosphate cement-release system for controlling infection and improving bone healing
Acta Biomater. Chen 8 3128 2012 10.1016/j.actbio.2012.04.030 Comparative study of osteogenic potential of a composite scaffold incorporating either endogenous bone morphogenetic protein-2 or exogenous phytomolecule icaritin: an in vitro efficacy study
Molecules Fan 16 10123 2011 10.3390/molecules161210123 The dose-effect of icariin on the proliferation and osteogenic differentiation of human bone mesenchymal stem cells
J. Mater. Sci. Mater. Med. Zhang 22 371 2011 10.1007/s10856-010-4198-y The effect of loading icariin on biocompatibility and bioactivity of porous beta-TCP ceramic
Biochem. Biophys. Res. Commun. Zhao 369 444 2008 10.1016/j.bbrc.2008.02.054 Icariin induces osteogenic differentiation in vitro in a BMP- and Runx2-dependent manner
Osteoarthritis Cartilage Shioji 19 S123 2011 10.1016/S1063-4584(11)60285-9 Effect of mechanical stress or its combination with mapk inhibitor on the chondrocytic phenotype of 3-dimensional scaffold-embedded rat chondrocytes
Mod. Rheumatol. Akiyama 18 213 2008 10.3109/s10165-008-0048-x Control of chondrogenesis by the transcription factor Sox9
Gene Dehne 462 8 2010 10.1016/j.gene.2010.04.006 Gene expression profiling of primary human articular chondrocytes in high-density micromasses reveals patterns of recovery, maintenance, re- and dedifferentiation
Tissue Eng. Vickers 12 1345 2006 10.1089/ten.2006.12.1345 Effects of cross-linking type II collagen-GAG scaffolds on chondrogenesis in vitro: dynamic pore reduction promotes cartilage formation
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.